The role of megakaryocyte impairment in ITP

(5:10)

New Rules for Overcoming ITP

(1:19:57)

Shifting the treatment landscape of ITP: novel agents and future outlooks

(1:32)

Treating Persistent/Chronic ITP Current Care, Future Potential

(45:50)

Recent advances in the treatment and management of ITP

(1:24)

Choosing New Agents for ITP

(2:4)

Newarc Platform | Shopping Mall | Live Withdraw Money Proof | Instant Withdraw | New Usdt Project |

(5:16)

What is the place for new treatments in ITP - Dr Drew Provan

(19:35)

Clinical Clips - Advancements in Pediatric ITP Management: Insights from EHA 2024

(13:32)

What’s new in ITP Treatment Presentation by Dr Drew Provan

(21:2)

ASH Clinical Practice Guidelines on Immune Thrombocytopenia (ITP)

(3:39)

Treating Persistent/Chronic ITP - Current Care, Future Potential

(1:12:2)

What is new in ITP? Prof. David Kuter

(20:3)

Immune Thrombocytopenia (ITP): Advances in Treatment in 2020

(14:7)

Immune Thrombocytopenia (ITP): Updated Review in 2020

(12:12)

What is new in ITP?

(1:33:20)

Modern Management of ITP: Thinking Beyond the Conventional Therapies

(33:6)

Childhood ITP | Dr. Vinay Munikoty Venkatesh | Manipal Hospital Yeshwanthpur

(4:42)

The Future of ITP Treatment

(6:44)

Key Insights: Real-World Evidence for ITP Treatment

(25:29)